Back to FDA Applications sponsored by PFIZER PHARMS

FDA Drug Application 020882 by PFIZER PHARMS

Application Number020882
Application Type New Drug Application
Sponsor ApplicantPFIZER PHARMS
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New formulation
Therapeutic Potential Standard
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP010/9/1998N465000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20882ltr.pdf 10/9/1998
AP010/9/1998N466000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20882.cfm 10/9/1998
AP010/9/1998N19006000   http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100192.htm 2/1/2008
AP010/9/1998N26658000   http://www.fda.gov/downloads/Drugs/DrugSafety/UCM229208.pdf 10/13/2010
AP010/12/2000SE12942002   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21216ltr.pdf 10/12/2000
AP010/12/2000SE12943002   http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21216lbl.pdf 10/12/2000
AP010/12/2000SE18532002   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-216_20-235S15_20-882S2_21-129S5_Neurontin.cfm 5/6/2004
AP09/19/2000SCM       
AP01/18/2002SCS       
AP01/30/2002SLR2939008   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21129s9ltr.pdf 1/30/2002
AP08/15/2002SE89260009   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20235se8-023,20882se8-009,21129se8-010ltr.pdf 6/10/2004
AP010/24/2002SCM       
AP012/19/2002SCS       
AP02/18/2005SLR11149015   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/20235s029,20882s015,21129s016ltr.pdf 2/23/2005
AP02/18/2005SLR11173015   http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20235s029,20882s015,21129s016lbl.pdf 2/23/2005
AP04/30/2004SCS8515017   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20882scs017ltr.pdf 5/4/2004
AP05/3/2006SLR14054021   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020235s035, 020882s021, 021129s020LTR.pdf 5/5/2006
AP03/1/2011SLR28089022   http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020235s036,020882s022,021129s022lbl.pdf 3/4/2011
AP03/1/2011SLR28109022   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020235s036,020882s022,021129s022ltr.pdf 3/7/2011
AP04/23/2009SLR22346028   http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020235s041,020882s028,021129s027lbl.pdf 4/28/2009
AP04/23/2009SLR22384028   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020235s041,020882s028ltr.pdf 5/1/2009
AP010/11/2010SLR26625030   http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020882s030lbl.pdf 10/11/2010
AP010/11/2010SLR26663030   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020235s043,020882s030,021129s029ltr.pdf 10/13/2010
AP08/10/2011SLR29743035   http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020235s050,020882s035,021129s033lbl.pdf 8/11/2011
AP08/10/2011SLR29756035   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020235s050,020882s035,021129s033ltr.pdf 8/12/2011
AP05/1/2013SLR35960038   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020235Orig1s054,s055,s056,020882Orig1s038,s039,s040,021129Orig1s035,s036,s037ltr.pdf 5/7/2013
AP05/1/2013SLR36009038   http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020235s054s055s056,020882s038s039s040,021129s035s036s037lbl.pdf 5/9/2013
AP05/1/2013SLR35961039   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020235Orig1s054,s055,s056,020882Orig1s038,s039,s040,021129Orig1s035,s036,s037ltr.pdf 5/7/2013
AP05/1/2013SLR36010039   http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020235s054s055s056,020882s038s039s040,021129s035s036s037lbl.pdf 5/9/2013
AP05/1/2013SLR35962040   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020235Orig1s054,s055,s056,020882Orig1s038,s039,s040,021129Orig1s035,s036,s037ltr.pdf 5/7/2013
AP05/1/2013SLR36011040   http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020235s054s055s056,020882s038s039s040,021129s035s036s037lbl.pdf 5/9/2013
AP08/18/2014SLR40282041   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/020235Orig1s057,020882Orig1s041,021129Orig1s039ltr.pdf 8/20/2014
AP08/18/2014SLR40286041   http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020235s057,020882s041,021129s039lbl.pdf 8/20/2014
AP09/14/2015SLR43898043   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020235Orig1s060,020882s043,021129Orig1s042ltr.pdf 9/17/2015
AP09/14/2015SLR43971043   http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020235s060,020882s043,021129s042lbl.pdf 9/23/2015
AP04/21/2015SLR42629044   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020235Orig1s061,020882Orig1s044,021129Orig1s043ltr.pdf 4/22/2015
AP04/21/2015SLR42666044   http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020235s061,020882s044,021129s043lbl.pdf 4/27/2015




Back to FDA Applications sponsored by PFIZER PHARMS